BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 32780661)

  • 21. Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma.
    Lyu J; Liu T; Li T; Li F; Wang Q; Wang J; Han Y; Wang J; Zhang J; Peng L; Lang J
    Cancer Med; 2019 Jul; 8(8):3710-3718. PubMed ID: 31119872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation-Induced Lymphopenia Predicts Poorer Prognosis in Patients With Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Trial of Postmastectomy Hypofractionated Radiation Therapy.
    Sun GY; Wang SL; Song YW; Jin J; Wang WH; Liu YP; Ren H; Fang H; Tang Y; Zhao XR; Song YC; Yu ZH; Liu XF; Li YX
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):277-285. PubMed ID: 32147519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
    Yadav BS; Sharma SC; Singh G; Dahiya D
    J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
    Haviland JS; Owen JR; Dewar JA; Agrawal RK; Barrett J; Barrett-Lee PJ; Dobbs HJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Simmons S; Sydenham MA; Venables K; Bliss JM; Yarnold JR;
    Lancet Oncol; 2013 Oct; 14(11):1086-1094. PubMed ID: 24055415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial.
    Chatterjee S; Chakraborty S;
    Trials; 2020 Sep; 21(1):819. PubMed ID: 32998747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypofractionated versus conventionally fractionated image-guided volumetric-modulated arc radiotherapy for localized prostate cancer: a phase II randomized trial from China.
    Zhong QZ; Xia X; Gao H; Xu YG; Zhao T; Wu QH; Wang D; Lin HL; Sha XY; Liu M; Li GF
    Aging (Albany NY); 2021 Feb; 13(5):6936-6944. PubMed ID: 33653964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis.
    Zayed S; Chen H; Ali E; Rodrigues GB; Warner A; Palma DA; Louie AV
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):575-586. PubMed ID: 32544575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer.
    Cante D; Petrucci E; Sciacero P; Piva C; Ferrario S; Bagnera S; Patania S; Mondini G; Pasquino M; Casanova Borca V; Vellani G; La Porta MR; Franco P
    Med Oncol; 2017 Sep; 34(9):152. PubMed ID: 28776318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Adjuvant Breast Hypofractionation Radiation Treatment at a Cancer Center in Ontario From 2011 to 2018.
    Lam E; Chan S; Karam I; Lee J; Wong G; Zhang L; Vesprini D; Wronski M; Chin L; Razvi Y; McKenzie E; Rakovitch E; Chow E
    Clin Breast Cancer; 2020 Oct; 20(5):e612-e617. PubMed ID: 32321680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress of clinical study on hypofractionated radiotherapy after breast-conserving surgery.
    Wei NN; Li F; Cai P; Yin HM; Zhu CM; Zhang Q; Li DJ
    Ann Palliat Med; 2020 Mar; 9(2):463-471. PubMed ID: 32233620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
    Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
    Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.
    Linares I; Tovar MI; Zurita M; Guerrero R; Expósito M; Del Moral R
    Clin Breast Cancer; 2016 Aug; 16(4):262-8. PubMed ID: 26454613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An accelerated hypofractionated schedule with a daily concomitant boost after breast conservation surgery: the feasibility and toxicity.
    Ghannam AA; Khedr RA
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):39-44. PubMed ID: 26833225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
    Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G
    Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
    Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
    Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.
    Corvò R; Giudici S; Maggio F; Bevegni M; Sampietro C; Lucido MR; Orsatti M
    Tumori; 2008; 94(5):706-11. PubMed ID: 19112945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing Hypofractionated With Conventional Fractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.
    Gu L; Dai W; Fu R; Lu H; Shen J; Shi Y; Zhang M; Jiang K; Wu F
    Front Oncol; 2021; 11():753209. PubMed ID: 34660318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer.
    Lee SW; Kim YJ; Shin KH; Kim K; Chie EK; Han W; Im SA; Jung SY; Lee KS; Lee ES
    Medicine (Baltimore); 2016 May; 95(19):e3320. PubMed ID: 27175630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.